262 related articles for article (PubMed ID: 22944479)
1. HIV treatment and care in resource-constrained environments: challenges for the next decade.
Eholié SP; Aoussi FE; Ouattara IS; Bissagnéné E; Anglaret X
J Int AIDS Soc; 2012 Aug; 15(2):17334. PubMed ID: 22944479
[TBL] [Abstract][Full Text] [Related]
2. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
Dutta A; Barker C; Kallarakal A
PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
[TBL] [Abstract][Full Text] [Related]
3. Challenges in implementing HIV laboratory monitoring in resource-constrained settings: how to do more with less.
Bélec L; Bonn JP
Future Microbiol; 2011 Nov; 6(11):1251-60. PubMed ID: 22082287
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of antiretroviral treatment monitoring in the era of decentralized HIV care: a systematic review.
Pham MD; Romero L; Parnell B; Anderson DA; Crowe SM; Luchters S
AIDS Res Ther; 2017 Jan; 14(1):3. PubMed ID: 28103895
[TBL] [Abstract][Full Text] [Related]
5. Human resources for treating HIV/AIDS: needs, capacities, and gaps.
Bärnighausen T; Bloom DE; Humair S
AIDS Patient Care STDS; 2007 Nov; 21(11):799-812. PubMed ID: 17944556
[TBL] [Abstract][Full Text] [Related]
6. Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis.
Walensky RP; Wood R; Ciaranello AL; Paltiel AD; Lorenzana SB; Anglaret X; Stoler AW; Freedberg KA;
PLoS Med; 2010 Dec; 7(12):e1000382. PubMed ID: 21209794
[TBL] [Abstract][Full Text] [Related]
7. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda.
Jain V; Chang W; Byonanebye DM; Owaraganise A; Twinomuhwezi E; Amanyire G; Black D; Marseille E; Kamya MR; Havlir DV; Kahn JG
PLoS One; 2015; 10(12):e0143433. PubMed ID: 26632823
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of ART in resource-limited countries.
Loubiere S; Meiners C; Sloan C; Freedberg KA; Yazdanpanah Y
Curr Opin HIV AIDS; 2010 May; 5(3):225-31. PubMed ID: 20539078
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness and cost implications of task-shifting in the delivery of antiretroviral therapy to HIV-infected patients: a systematic review.
Mdege ND; Chindove S; Ali S
Health Policy Plan; 2013 May; 28(3):223-36. PubMed ID: 22738755
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of highly active antiretroviral therapy in HIV infection.
Walker AS; Gibb DM
Curr Opin Infect Dis; 2011 Feb; 24(1):27-33. PubMed ID: 21150591
[TBL] [Abstract][Full Text] [Related]
11. Time for "test and treat" in prevention of mother-to-child transmission programs in low- and middle-income countries.
Zolfo M; De Weggheleire A; Schouten E; Lynen L
J Acquir Immune Defic Syndr; 2010 Nov; 55(3):287-9. PubMed ID: 20714271
[TBL] [Abstract][Full Text] [Related]
12. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
13. When to start antiretroviral therapy in resource-limited settings.
Walensky RP; Wolf LL; Wood R; Fofana MO; Freedberg KA; Martinson NA; Paltiel AD; Anglaret X; Weinstein MC; Losina E;
Ann Intern Med; 2009 Aug; 151(3):157-66. PubMed ID: 19620143
[TBL] [Abstract][Full Text] [Related]
14. Routine viral load monitoring in HIV-infected infants and children in low- and middle-income countries: challenges and opportunities.
Arpadi SM; Shiau S; De Gusmao EP; Violari A
J Int AIDS Soc; 2017 Nov; 20 Suppl 7(Suppl 7):. PubMed ID: 29171190
[TBL] [Abstract][Full Text] [Related]
15. National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?
Beck EJ; Vitoria M; Mandalia S; Crowley S; Gilks CF; Souteyrand Y
AIDS; 2006 Jul; 20(11):1497-502. PubMed ID: 16847404
[TBL] [Abstract][Full Text] [Related]
16. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
Chang LW; Harris J; Humphreys E
Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
[TBL] [Abstract][Full Text] [Related]
17. Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy.
Kredo T; Adeniyi FB; Bateganya M; Pienaar ED
Cochrane Database Syst Rev; 2014 Jul; (7):CD007331. PubMed ID: 24980859
[TBL] [Abstract][Full Text] [Related]
18. Maximizing the benefits of antiretroviral therapy for key affected populations.
Grubb IR; Beckham SW; Kazatchkine M; Thomas RM; Albers ER; Cabral M; Lange J; Vella S; Kurian M; Beyrer C;
J Int AIDS Soc; 2014; 17(1):19320. PubMed ID: 25043380
[TBL] [Abstract][Full Text] [Related]
19. Providing universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS care.
Bemelmans M; van den Akker T; Ford N; Philips M; Zachariah R; Harries A; Schouten E; Hermann K; Mwagomba B; Massaquoi M
Trop Med Int Health; 2010 Dec; 15(12):1413-20. PubMed ID: 20958897
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
